Global Cell Therapy Biomanufacturing Market Size To Exceed USD 45.95 Billion by 2035
Category: HealthcareGlobal Cell Therapy Biomanufacturing Market to Exceed $ 45.95Billion by 2035
According to a research report published by Spherical Insights & Consulting, the Global Cell Therapy Biomanufacturing Market is expected to grow from USD 7.37 billion in 2024 to USD 45.95billion by 2035, at a CAGR of 18.10% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 210 pages with 140 Market data tables and figures & charts from the report on the Global Cell Therapy Biomanufacturing Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Consumables, Equipment, and Systems & Software), By End User (Biopharmaceutical Biotechnology Companies, Research Institutes, Cell Banks, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/cell-therapy-biomanufacturing-market
The cell therapy biomanufacturing market is the worldwide industry that creates, manufactures, and distributes living cell-based medications for the treatment of various diseases. It encompasses all of the tools, processes, and infrastructure required to cultivate, modify, and scale therapeutic cells while meeting stringent quality and legal standards. The main objectives of the cell therapy biomanufacturing market are the discovery, optimization, and mass production of therapeutic cell products that ensure quality, regulatory compliance, and efficient delivery for clinical and commercial applications. The market for cell therapy biomanufacturing is being driven by a number of factors, including increased investment from biotech and pharmaceutical companies, growth in clinical trials for cell-based treatments, improvements in cell processing technologies, and the increasing demand for personalized and regenerative drugs. Customers and other stakeholders are collaborating with biomanufacturing companies to improve clinical research and commercial manufacturing of these drugs. Consequently, it is projected that the market for cell therapy biomanufacturing would grow. However, the expansion of the cell therapy biomanufacturing market is constrained by high production costs, intricate regulatory processes, limited scalability, a dearth of experienced workers, and raw material variability.
The consumables segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product type, the cell therapy biomanufacturing market is divided into consumables, equipment, and systems & software. Among these, the consumables segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The largest market share in cell therapy biomanufacturing is held by consumables segments due to consumables, including growth factors, reagents, cell culture media, and single-use bioreactors, which are used continuously throughout the manufacturing process, generating repeat business and steady demand.
The biopharmaceutical biotechnology companies segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end user, the cell therapy biomanufacturing market is divided into biopharmaceutical biotechnology companies, research institutes, cell banks, and others. Among these, the biopharmaceutical biotechnology companies segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Biopharmaceutical and biotechnology companies own the cell therapy and are responsible for its development, clinical testing, and commercialization.
North America is expected to hold the majority share of the global cell therapy biomanufacturing market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global cell therapy biomanufacturing market during the forecast period. North America is known for its highly developed healthcare system and robust regulatory support. According to the USPTO study, Boston and San Diego, two densely populated industrial regions that benefit the area, are the origin of 70% of cell treatment patents globally.
Asia Pacific is anticipated to grow at the fastest pace in the global cell therapy biomanufacturing market during the forecast period. Strong rules and substantial R&D expenditures have also placed the region's major countries, China, India, Japan, and South Korea, at the forefront of this economic trajectory. Additionally, Asia Pacific's aging population is contributing to a surge in demand for tailored treatment.
Major vendors in the global cell therapy biomanufacturing market are BD, Lonza, Sartorius AG, Bio-Techne., Merck KGaA, Miltenyi Biotec, Eppendorf SE, PBS Biotech, Inc., Repligen Corporation, Corning Incorporated, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Bharat Biotech International Limited., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In March 2025, A leader in low-cost domestic vaccine development and production, Bharat Biotech International Limited (BBIL), today announced its entry into the fields of cell and gene therapy (CGT) and viral vector production at Genome Valley. This move broadens the company's expertise beyond vaccine development to include cutting-edge regenerative and customized therapies that offer millions of people hope.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the cell therapy biomanufacturing market based on the below-mentioned segments:
Global Cell Therapy Biomanufacturing Market, By Product Type
By Product Type, By End User
- Consumables
- Equipment
- Systems & Software
Global Cell Therapy Biomanufacturing Market, By End User
- Biopharmaceutical Biotechnology Companies
- Research Institutes
- Cell Banks
- Others
Global Cell Therapy Biomanufacturing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?